(TICAGRELOR)
(EXENATIDE)
(EXENATIDE)
(ACALABRUTINIB)
(ROFLUMILAST)
(TRASTUZUMAB DERUXTECAN)
(TIXAGEVIMAB + CILGAVIMAB)
(BENRALIZUMAB)
(FULVESTRANT)
(INFLUENZA VACCINE (LIVE ATTENUATED, NASAL))
(DAPAGLIFLOZIN)
(DURVALUMAB)
(TREMELIMUMAB)
(GEFITINIB)
(SEBELIPASE ALFA)
(SAXAGLIPTIN + METFORMIN)
(SELUMETINIB)
(SODIUM ZIRCONIUM CYCLOSILICATE)
(OLAPARIB)
(TAMOXIFEN)
(ANDEXANET ALFA)
(SAXAGLIPTIN)
(BUDESONIDE)
(BUDESONIDE)
(ANIFROLUMAB)
(ECULIZUMAB)
(ASFOTASE ALFA)
(pMDI) (BUDESONIDE + FORMOTEROL FUMARATE DIHYDRATE) (160+4,5) MCG/ACTUATION
(pMDI) (BUDESONIDE + FORMOTEROL FUMARATE DIHYDRATE) (80+2,25) MCG/ACTUATION
(BUDESONIDE + FORMOTEROL FUMARATE DIHYDRATE) INH.PD, (160+4,5) MCG/INH
(BUDESONIDE + FORMOTEROL FUMARATE DIHYDRATE) INH.PD, (80+4,5) MCG/INH
(BUDESONIDE + FORMOTEROL FUMARATE DIHYDRATE) INH.PD, (320+9) MCG/INH
(PALIVIZUMAB)
(OSIMERTINIB)
(TEZEPELUMAB)
(FORMOTEROL FUMARATE DIHYDRATE + GLYCOPYRRONIUM BROMIDE + BUDESONIDE)
(RAVULIZUMAB)
(DANICOPAN)
(DAPAGLIFLOZIN + METFORMIN)
(GOSERELIN) INJ.IMPL, 3,6 MG
(GOSERELIN) INJ.IMPL, 10,8 MG
Ο ιστότοπος αυτός προορίζεται αποκλειστικά και μόνο για τους Επαγγελματίες Υγείας που εργάζονται στην Ελλάδα.
©2020 AstraZeneca. Με την επιφύλαξη παντός δικαιώματος.
GR-9025
Τελευταία αναθεώρηση 08/24
